Prediction of Functional Recovery and Survival in Patients with Spinal Metastases Using Clinical Variables and PathFx

Internal Validation of an Integrated Prediction Model for Management DecisionMaking in Spinal Metastases: Combining PathFx Survival Estimates with Pre-Treatment Clinical Variables

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202606496344344

Enrollment

Registered

2026-06-04

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Musculoskeletal Diseases Orthopaedics

Interventions

Observational prognostic assessment using PathFx and clinical variables

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients aged 21 years or older. ? Radiologically confirmed spinal metastases (MRI and/or CT). ? Patients undergoing treatment for spinal metastases . ? Presence of pain, neurological deficit, or spinal instability requiring active management. ? Ability to provide informed consent and comply with follow-up assessments.

Exclusion criteria

Exclusion criteria: Primary spinal tumors. ? Active spinal infection. ? Incomplete clinical data or loss to follow-up.

Design outcomes

Primary

Measure	Time frame
Functional recovery after management of spinal metastases	—

Secondary

Measure	Time frame
Overall survival prediction accuracy using integrated PathFx model;ambulatory status complication rate mortality	—

Countries

Egypt

Contacts

Public ContactAhmed Mansour

Orthopaedic surgery and spine specialist at Egyption ministry of health and populations

Draaam8@gmail.com+201118603074

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026